Publications
-
Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy.
Witteles RM,
Keu KV, Quon A, Tavana H, Fowler MB.
J Card Fail.
2012;
18
(10):
804-9
-
Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented?
Witteles RM,
Fowler MB, Telli ML.
Heart Fail Clin.
2011;
7
(3):
333-44
-
Dyssynchrony Assessment with Tissue Doppler Imaging and Regional Volumetric Analysis by 3D Echocardiography Do Not Predict Long-Term Response to Cardiac Resynchronization Therapy.
Kuppahally SS,
Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Hsia H, Liang D.
Cardiol Res Pract.
2010:
2011
568918
-
Measurement precision in the optimization of cardiac resynchronization therapy.
Turcott RG,
Witteles RM, Wang PJ, Vagelos RH, Fowler MB, Ashley EA.
Circ Heart Fail.
2010;
3
(3):
395-404
-
Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy.
Kuppahally SS,
Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D.
Echocardiography.
2009;
26
(7):
759-65
-
Hypertension, heart failure, and beta-adrenergic blocking drugs.
Fowler MB,
J Am Coll Cardiol.
2008;
52
(13):
1073-5
-
Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options.
Witteles RM,
Fowler MB.
J Am Coll Cardiol.
2008;
51
(2):
93-102
-
Beta-blocker dosing in community-based treatment of heart failure.
Fowler MB,
Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie BM, Abraham WT, Franciosa JA.
Am Heart J.
2007;
153
(6):
1029-36
-
Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.
Witteles RM,
Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB.
J Am Coll Cardiol.
2007;
50
(19):
1835-40
-
Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness.
Kuppahally SS,
Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, Fowler M, Vagelos R, Perlroth MG, Robbins RC, Hunt SA.
Am J Transplant.
2007;
7
(10):
2388-95
-
The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA,
Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A.
Pacing Clin Electrophysiol.
2007;
30
(3):
390-4
-
Why do we need to prevent right ventricular pacing?
Tsiperfal A,
Scheibly K, Fowler MB, Chao C.
Prog Cardiovasc Nurs.
2007;
22
(2):
108-9
-
Cardiomyopathy of insulin resistance.
Witteles RM,
Fowler MB.
Heart Fail Clin.
2006;
2
(1):
13-23
-
Emerging therapies for the management of decompensated heart failure: from bench to bedside.
deGoma EM,
Vagelos RH, Fowler MB, Ashley EA.
J Am Coll Cardiol.
2006;
48
(12):
2397-409
-
Care management for low-risk patients with heart failure: a randomized, controlled trial.
DeBusk RF,
Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, West JA, Fowler MB, Greenwald G.
Ann Intern Med.
2004;
141
(8):
606-13
-
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure.
Fowler MB,
Am J Cardiol.
2004;
93
(9A):
35B-9B
-
Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.
Witteles RM,
Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB.
J Am Coll Cardiol.
2004;
44
(1):
78-81
-
Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.
Chen MM,
Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh T, Dargie H, Yakhini Z, Tsao PS, Quertermous T.
Circulation.
2003;
108
(12):
1432-9
-
Beta-adrenergic blocking drugs in severe heart failure.
Fowler M,
Rev Cardiovasc Med.
2002:
3 Suppl 3
S20-6
-
Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
Tang WH,
Vagelos RH, Yee YG, Benedict CR, Willson K, Liss CL, Fowler MB.
J Am Coll Cardiol.
2002;
39
(1):
70-8
-
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
Fowler MB,
Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M.
J Am Coll Cardiol.
2001;
37
(6):
1692-9
-
The role of angiotensin receptor blockers in the management of chronic heart failure.
Jamali AH,
Tang WH, Khot UN, Fowler MB.
Arch Intern Med.
2001;
161
(5):
667-72
-
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited.
Myers J,
Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB.
Am Heart J.
2000;
139
(1 Pt 1):
78-84
-
Spontaneous postpartum coronary dissection.
Lee FH,
Yeung AC, Fowler MB, Fitzgerald PJ.
Circulation.
1999;
99
(5):
721
-
The influence of beta-adrenergic blocking drugs on morbidity and mortality in heart failure.
Fowler MB,
J Cardiovasc Risk.
1999;
6
(3):
141-4
-
Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation.
Gullestad L,
Haywood G, Aass H, Ross H, Yee G, Ueland T, Geiran O, Kjekshus J, Simonsen S, Bishopric N, Fowler M.
Cardiovasc Res.
1998;
38
(2):
340-7
-
Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB,
Eur Heart J.
1998:
19 Suppl P
P17-25
-
Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation.
Gullestad L,
Aass H, Ross H, Ueland T, Geiran O, Kjekshus J, Simonsen S, Fowler M, Kobilka B.
J Auton Nerv Syst.
1998;
70
(1-2):
84-91
-
Serial exercise testing and prognosis in selected patients considered for cardiac transplantation.
Gullestad L,
Myers J, Ross H, Rickenbacher P, Slauson S, Bellin D, Do D, Vagelos R, Fowler M.
Am Heart J.
1998;
135
(2 Pt 1):
221-9
-
Use of assumed versus measured oxygen consumption for the determination of cardiac output using the Fick principle.
Wolf A,
Pollman MJ, Trindade PT, Fowler MB, Alderman EL.
Cathet Cardiovasc Diagn.
1998;
43
(4):
372-80
-
Assessment of left ventricular wall motion abnormalities with the use of color kinesis: a valuable visual and training aid.
Lau YS,
Puryear JV, Gan SC, Fowler MB, Vagelos RH, Popp RL, Schnittger I.
J Am Soc Echocardiogr.
1997 Jul-Aug;
10
(6):
665-72
-
AT1 and AT2 angiotensin receptor gene expression in human heart failure.
Haywood GA,
Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB.
Circulation.
1997;
95
(5):
1201-6
-
Effects of beta blockers on symptoms and functional capacity in heart failure.
Fowler MB,
Am J Cardiol.
1997;
80
(11A):
55L-58L
-
Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.
Haywood GA,
Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, Vagelos R, Oyer P, Fowler MB.
Heart.
1996;
75
(5):
455-62
-
Exercise capacity of heart transplant recipients: the importance of chronotropic incompetence.
Gullestad L,
Haywood G, Ross H, Bjornerheim R, Geiran O, Kjekshus J, Simonsen S, Fowler M.
J Heart Lung Transplant.
1996;
15
(11):
1075-83
-
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.
Lewis NP,
Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindade PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, Fowler MB.
Circulation.
1996;
93
(4):
720-9
-
Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
Rickenbacher PR,
Trindade PT, Haywood GA, Vagelos RH, Schroeder JS, Willson K, Prikazsky L, Fowler MB.
J Am Coll Cardiol.
1996;
27
(5):
1192-7
-
Selecting candidates for cardiac transplantation. How to assess exclusion criteria and predict who will benefit.
Rickenbacher PR,
Haywood G, Fowler MB.
J Crit Illn.
1995;
10
(3):
199-206
-
Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats.
Deisher TA,
Ginsburg R, Fowler MB, Billingham ME, Bristow MR.
Am J Cardiovasc Pathol.
1995;
5
(1):
79-88
-
The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction.
Alpert S,
Lewis NP, Ross H, Fowler M, Valantine HA.
Transplantation.
1995;
60
(12):
1478-85
-
Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromide.
Kindman LA,
Vagelos RH, Willson K, Prikazky L, Fowler M.
Am J Cardiol.
1994;
73
(4):
258-62
-
Incidence of myocarditis in peripartum cardiomyopathy.
Rizeq MN,
Rickenbacher PR, Fowler MB, Billingham ME.
Am J Cardiol.
1994;
74
(5):
474-7
-
Long-term outcome after heart transplantation for peripartum cardiomyopathy.
Rickenbacher PR,
Rizeq MN, Hunt SA, Billingham ME, Fowler MB.
Am Heart J.
1994;
127
(5):
1318-23
-
Beta-blockers in heart failure: potential of carvedilol.
Fowler MB,
J Hum Hypertens.
1993:
7 Suppl 1
S62-7
-
Controlled trials with beta blockers in heart failure: metoprolol as the prototype.
Fowler MB,
Am J Cardiol.
1993;
71
(9):
45C-53C
-
Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
Deisher TA,
Narita H, Zera P, Ginsburg R, Bristow MR, Billingham ME, Fowler MB, Hoffman BB.
J Pharmacol Exp Ther.
1993;
266
(1):
262-9
-
Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.
Costard-Jäckle A,
Fowler MB.
J Am Coll Cardiol.
1992;
19
(1):
48-54
-
The influence of preoperative patient characteristics on early and late survival following cardiac transplantation.
Costard-Jäckle A,
Hill I, Schroeder JS, Fowler MB.
Circulation.
1991;
84
(5 Suppl):
III329-37
-
Cardiac adrenoceptors in the failing heart: effect of intervention.
Fowler MB,
Eur Heart J.
1990:
11 Suppl A
13-8
-
Selection of patients for cardiac transplantation.
Vagelos R,
Fowler MB.
Cardiol Clin.
1990;
8
(1):
23-38
-
Hemodynamic effects of high dose naloxone in congestive heart failure.
Kindman LA,
Fowler MB.
Am J Cardiol.
1989;
64
(8):
542-4
-
Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.
Heilbrunn SM,
Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB.
Circulation.
1989;
79
(3):
483-90
-
Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure.
Molina CR,
Fowler MB, McCrory S, Peterson C, Myers BD, Schroeder JS, Murad F.
J Am Coll Cardiol.
1988;
12
(1):
175-86
-
Orthotopic cardiac transplantation for univentricular heart.
Macoviak JA,
Baldwin JC, Ginsburg R, Fowler M, Valentine H, Oyer PE, Stinson EB.
Ann Thorac Surg.
1988;
45
(1):
85-6
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help